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p-Extended Diaza[7]helicenes by Hybridization of Naphthalene
Diimides and Hexa-peri-hexabenzocoronenes
Carolin Dusold,[a] Dmitry I. Sharapa,[b] Frank Hampel,[a] and Andreas Hirsch*[a]
Abstract: The synthesis of an unprecedented, p-extended
hexabenzocorene (HBC)-based diaza[7]helicene is presented.
The target compound was synthesized by an ortho-fusion of
two naphthalene diimide (NDI) units to a HBC-skeleton. A
combination of Diels–Alder and Scholl-type oxidation reac-
tions involving a symmetric di-NDI-tolane precursor were
crucial for the very selective formation of the helical super-
structure via a hexaphenyl-benzene (HPB) derivative. The for-
mation of the diaza[7]helicene moiety in the final Scholl oxi-
dation is favoured, affording the symmetric p-extended heli-
cene as the major product as a pair of enantiomers. The sep-
aration of the enantiomers was successfully accomplished
by HPLC involving a chiral stationary phase. The absolute
configuration of the enantiomers was assigned by compari-
son of circular dichroism spectra with quantum mechanical
calculations.
Introduction
The development of nonplanar PAHs is currently an emerging
field in synthetic organic chemistry.[1] Among the most impor-
tant starting points for this progress is the discovery of the
parent helicenes.[2] Since then, research groups all over the
world further elaborated the investigation and understanding
of helicene chemistry, with great success.[3] Outstanding chi-
roptical properties,[4] such as inducing the emission of circularly
polarized light, large optical rotation values and pronounced
circular dichroism bands make them very attractive for applica-
tions in nonlinear optics,[5] asymmetric synthesis,[6] chiroptical
switches,[7] and organic semiconductors.[8] Next to the classical
carbohelicenes, heterohelicenes, which include one or more
heteroaromatic rings such as pyridine, pyrrole, and thiophene
are receiving growing interest and it was realized that their
property combinations can even surpass those of the conven-
tional all-carbon analogues.[9] Furthermore, the p-extension of
the basic helicene skeleton is of considerable interest since it
can notably tune optical, electronical and supramolecular
properties.[10] Elongation of the spiral arrangement of the con-
jugated p-system represents the most common way to pre-
pare higher helicene derivatives.[11] In contrast to that, the ex-
pansion of the conjugated system on the outer rim is still a
challenging issue. Recently, a lot of progress has been made
on the lateral extension of helicenes,[10a, 12] including p-extend-
ed helicenes based on perylene diimide,[13] pyrene[14] and hexa-
peri-hexabenzocoronene (HBC).[15] Especially the use of HBC
subunits enables the design of new „superhelicenes“,[15a] repre-
senting new proto-types in the field of chiral nanographene.
Such helically twisted graphenes can be considered as promis-
ing candidates in the field of chiral electronics,[16] not only due
to their outstanding chiroptical properties, but also due to an
enhanced p–p stacking relative to the parent helicene, which
is crucial to achieve efficient charge carrier transportation,[17]
and an improved solubility compared to their planar ana-
logues.[18] In this contribution, we will expand the concept of
HBC-based helicenes by introducing additional aromatic subu-
nits to further extend the conjugated p-system. We have se-
lected naphthalene diimides (NDIs) as promising candidates
since they feature desirable chemical and (opto)electronical
properties themselves.[19] As a consequence, we accomplished
an ortho-fusion of two NDI units to an HBC-skeleton, generat-
ing an unprecedented, p-extended HBC-based heterohelicene.
The high degree of pre-organization of the diaza[7]helicene
subunit results in the formation of a chiral compound with
two NDI arms lying on top of each other (Figure 1).
This helical superstructure combines not only the advantag-
es of lateral p-extended helicenes with those of azahelicenes,
at the same time, the fusion of two NDI arms enables the gen-
eration of an extensive conjugated p-surface all over the mole-
cule. Photophysical investigations were carried out and the
corresponding enantiomers were separated in order to deter-
mine their chiroptical properties.
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Our strategy to synthesise the p-extended HBC-based diaza[7]-
helicene HBC 3 relies on the combination of standard Diels–
Alder and Scholl-type reactions (Scheme 1).
The key intermediate of our synthetic concept is the tolane
derivative 1 containing two symmetrically fused NDI units. The
symmetric constitution of the corresponding di-NDI-hexaphen-
yl-benzene (HPB) (2) is crucial to generate the desired 7-helical
moiety in the final HBC. The synthetic sequence started with
the preparation of the symmetric precursor 1 as illustrated in
Scheme 2.
The first step was the palladium-catalysed Sonogashira
cross-coupling reaction between tert-butyloxycarbonyl (boc)-
protected alkyne 4 and 4-bromo-1,2-naphthaleneimidebenzi-
midazole (5). The required boc-protected alkyne building block
4 was prepared according to literature procedures,[20] starting
with the protection of diamino-bromobenzene (11) to enable
the successful performance of the subsequent Sonogashira
coupling reactions, followed by deprotection of the TMS-group
(see Supporting Information S1 for synthetic details). The
second building block NDI-compound 5 was prepared via con-
densation of naphthalene monoimide (8) with diamino-bromo-
benzene (11) (Scheme 3). During this reaction, two constitu-
tional isomers are formed, 5 as well as 5-bromo-1,2-naphthale-
neimidebenzimidazole (12). The two compounds can easily be
separated by column chromatography, isolating the first yellow
fraction in 42 % yield, and the second orange fraction in 36 %
yield. Although the NMR and optical spectra of both com-
pounds differ significantly as shown in Scheme 3 (for further
information see Supporting Information S2), clear structural as-
signment was not possible at this point. However, crystals of
the orange fraction suitable for X-ray diffraction analysis were
grown by slow evaporation of a solution of the compound in
dichloromethane (DCM) at room temperature. Small needles
were obtained, and the quality of the X-ray analysis was suffi-
cient for unambiguous structure assignment (see Supporting
Information S2 for further information). Thus, a secure assign-
ment of the orange fraction to the 5 isomer is possible as de-
picted in Figure 2.
The boc-protected NDI-tolane 6 synthesised by Sonogashira
reaction was obtained in a pure form in good yields of 82 %
(Scheme 2). The boc-protecting group was removed using
TFA[21] to afford the free diamino functionality. Due to the sen-
sitivity towards oxidation of such aminotolane compounds,[22]
the crude product 7 was used directly in the next condensa-
tion reaction with 8 without further purification or characteri-
sation to generate di-NDI-tolane precursors 1 and 9 with an
overall yield of 56 %. The new fused naphthalene benzimida-
zole moiety is once again formed as two constitutional iso-
mers. One the one hand, a symmetrical compound 1 is formed
in which the introduced naphthalene monoimide is connected
to the tolane in a binding pattern similar to the already exist-
ing naphthalene-benzimidazole unit, highlighted in blue in
Scheme 2. On the other hand, an asymmetric tolane is formed
when the naphthalene monoimide is fused to the tolane in an
alternative binding pattern, highlighted in red. The asymmetric
tolane 9 is not a suitable precursor for the targeted p-extend-
ed HBC-based diaza[7]helicene HBC 3, since planarization of
the corresponding asymmetrical HPB 10 would not result in
the desired 7-helical structure in the end. The symmetrical di-
NDI tolane 1 with both NDI units fused to it through the blue
binding pattern is essential for the formation of the helical su-
perstructure in the final compound. Unfortunately, isomers 1
and 9 could not be separated at this stage. Hence, the fused
di-NDI-tolane was reacted as a mixture of isomers in the subse-
quent Diels–Alder reaction with tetrakis-(tert-butyl)tetracyclo-
ne[15a, 23] at 220 8C to generate the corresponding di-NDI HPBs 2
Figure 1. General structure of a chiral, p-extended diaza[7]helicene based on
HBC and NDI.
Scheme 1. Synthetic concept to generate 7-helical HBC 3.
Figure 2. Crystal structure of 4-bromo-1,2-naphthaleneimidebenzimidazole
(5).




Scheme 2. Synthesis of symmetric and asymmetric di-NDI HPBs 2 and 10. a) PdCl2(PPh3)2, CuI, Et3N, toluene, 80 8C, 18 h, yield 82 %. b) TFA, DCM, RT, 3 h.
c) DMF, 140 8C, 18 h, yield 56 %. d) Tetrakis-(tert-butyl)tetracyclone, toluene, 220 8C, 24 h, yield 29 % (2) and 30 % (10).
Scheme 3. Synthesis of the naphthalene imide benzimidazole isomers 5 (orange) and 12 (black) and their 1H NMR and UV/Vis absorption spectra. a) Imidazole,
160 8C, 3 h, yield 36 % (5) and 42 % (12).




and 10. At this stage the two isomers could easily be separat-
ed by column chromatography in pure form. Symmetrical HPB
2 was obtained in 29 % and asymmetrical HPB 10 in 30 % yield.
For the final transformation of di-NDI HPB 2 Scholl oxidation
conditions using FeCl3 were applied. After 18 h, complete con-
versation of the starting material was observed, and new dark-
green compounds were traced by TLC. The crude mixture was
separated by HPLC (see Supporting Information S3). Next to
the expected molecules 3, 13 and 14 several minor side-prod-
ucts were detected, in particular chlorinated side-products as
well as compounds with one bond of the HBC core still not
closed. However, the major fraction of the reaction was identi-
fied as the product by mass spectrometry. In Scheme 4, the
structure of the three constitutional isomers formed during the
final Scholl oxidation, namely, the two symmetrical isomers 13
and 3 and the asymmetrical isomer 14 is depicted.
HPLC separation resulted in exclusive isolation of fraction 3,
which was analysed by NMR spectroscopy. The important re-
gions of the proton 1H NMR spectrum are displayed in
Figure 3. The spectrum reveals a defined set of signals, already
indicating the existence of one pure compound instead of a
mixture of isomers. In the aromatic area five signals for the
protons of the HBC are present between 9.32–10.03 ppm and
four signals between 8.19–9.06 ppm that can be assigned to
the NDI hydrogen atoms. Moreover, only one resonance can
be found at 4.92 ppm (N-CH) and the protons of the tert-butyl
groups of the HBC unit appear as only two singlets at 1.85 and
1.80 ppm. The appearance of only one set of resonances sug-
gest that the isolated compound must be symmetrical, which
is consistent with either the desired 7-helical HBC 3 or HBC 13.
For an unambiguous structural assignment, additional 1D
and 2D NMR experiments were performed (see Supporting In-
formation S4). The 1H-COSY-NMR spectrum exhibits the cou-
pling of the aromatic hydrogen atoms, except for the HBC pro-
tons at 10.03 ppm, which features no such correlation. This
characteristic is in principle still compatible for hydrogen
atoms H1 (highlighted in orange) for both symmetrical isomers
(Scheme 4). However, 1D-ROESY NMR spectroscopy shows that
selective excitation of this resonance at 10.03 ppm results in a
strong signal at 9.58 ppm. Since hydrogen atoms H1 of HBC
13 are completely isolated, no NOE (nuclear Overhauser effect)
signal is expected, unlike the H atoms H1 of HBC 3, which ex-
hibit neighbouring protons at the HBC-rim. Thus, this is a first
indication that the isolated fraction is the desired, isometrically
pure diaza[7]helicene HBC 3. Hence, Scholl oxidation of sym-
metric di-NDI HPB 2 favours the formation of the 7-helical
structure. One possible explanation for this could be the p–p
interaction of the two NDI units that is most pronounced once
they lie on top of each other causing a suitable pre-orientation
of the HPB. As a result, 7-helical HBC 3 is formed as the major
compound which was isolated in 43 % yield. HBC 13 and 14
were formed only in minor quantities (<1 mg) and could not
be isolated. The structural assignment is supported by a very
Scheme 4. Final Scholl-oxidation of HPB 2 leading to the three possible isomers symmetrical HBC 13, 7-helical HBC 3, and asymmetrical HBC 14 ; hydrogen
atoms without COSY-correlation: H1 highlighted in orange a) FeCl3, CH3NO2, DCM, 0 8C, o.n. (overnight), yield 43 %.
Figure 3. Important regions of the 1H-NMR spectrum of 7-helical HBC 3.




good resolution of all NMR spectra of HBC 3, which were re-
corded at room without the necessity to perform high-temper-
ature measurements. It is expected that such extended aro-
matic systems form intermolecular aggregates due to strong
p–p interactions, which would drastically decrease the solubili-
ty. Thus, compound 13 should not be resolvable at room tem-
perature. However, the nonplanar helicene subunit and the in-
herent three-dimensional twist of HBC 3 provides excellent sol-
ubility in a very large variety of organic solvents. In compari-
son, the symmetrical HPB 2 shows a much lower solubility and
thus, high-temperature NMR measurement were needed to
obtain spectra with good resolution (see Supporting Informa-
tion S5). The transformation of di-NDI-HPB 2 to the corre-
sponding HBC 3 can be monitored by UV/Vis absorption spec-
troscopy as well (Figure 4). After Scholl oxidation, HCB 2 dis-
plays a new strong absorption signature due to the HBC unit
at 372 nm with a high molar extinction coefficient of
54 000 L mol@1 cm@1. At the same time, the NDI absorption
broadens and experiences a strong red shift of 100 nm to
571 nm. In addition, the intensity decreases from extinction co-
efficient values of around 25 000 to 11100 L mol@1 cm@1.
Emission properties were investigated upon irradiation at
the corresponding absorption maximum. Although the starting
material 5 exhibits a very strong fluorescence with a maximum
at 570 nm, the emission intensity is already drastically de-
creased for di-NDI tolane mixture 1/9 as well as for HPB 2. Fi-
nally, the fluorescence of the 7-helical HBC 3 is completely
quenched, and no emission is detected any more (see Sup-
porting Information S6).
Since compound 3 contains a diaza[7]helicene unit, it is a
chiral molecule and can adopt either (M)- or (P)-configuration
(Figure 5 A). In order to separate the enantiomers, we targeted
HPLC using a chiral Chiralpak 1BN-5 column. Indeed, we were
able to separate the two enantiomers with retention times of
tR = 14.7 min and tR = 31.3 min. This allowed us to analyse their
chiroptical properties with circular dichroism (CD) spectroscopy
(Figure 5 B + C). The mirror image spectra display five strong
Cotton effects in the ultraviolet and visible region between
260–340 nm, 365–390 nm, 390–430 nm, 430–460 nm and 580–
730 nm with corresponding jDe j of 33, 25, 16, 15 and
10 L mol@1 cm@1, respectively. The calculated dissymmetry fac-
tors jgabs j reach a maximum of 1.5 V 10@3. In addition, we con-
ducted DFT calculations (Figure 6) to gain information about
the 3D-structure of 3.
Traditionally, p–p stacking is better described by dispersion-
corrected than by dispersion-devoid DFT. However, there are
some works claiming that in condensed phase the uncorrected
approach might be more consistent with reality.[24] Thus, we
performed optimisation both with B3LYP/def2-SVP (Figure 6)
and B3LYP-D3/def2-SVP (Figure S28) and for both geometries
CD-spectra were simulated with same methodology (sTD-CAM-
B3LYP/def2-TZVP, see S7 + S8 for details). Although the elec-
tronic structure (Figure 6 D) is very consistent for both ob-
tained geometries (the highest occupied molecular orbital
(HOMO) is mainly delocalized on the HBC unit while the lowest
unoccupied molecular orbital (LUMO) is equally localized on
both NDI moieties), the obtained geometries differ significantly
in the interplanar distance of the two NDI-wings. This indeed
shifts and effects the intensity of peaks in the long-wave part
of the CD-spectra that corresponds to excitations with signifi-
cant role of the LUMO. Nevertheless, the general pattern of
the spectra stays the same for both geometries and is in good
agreement with the experimentally measured spectra (espe-
cially in the area between 350–500 nm, see Figure 5 C). Thus,
the first eluted fraction was assigned as (M)- and the second
eluted fraction as (P)-isomer. Furthermore, characteristic helici-
ty values such as torsion angles and interplanar angle, were
analysed. The inner helix with corresponding torsion angles as
well as the interplanar angle is shown in Figure 6 B and 6C, re-
spectively. The seven rings form a helicene subunit with an
overall sum of torsion angles a–e of q= 958–1068 (with and
without dispersion correction). This value is between the ones
of previously reported [7]-helicenes, for example, all carbon
[7]-helicenes (sum of torsion angles 1088 @1348)[3h, 10a] or [7]-
azahelicenes (sum of torsion angles 80.28).[9a, 25]
First titration experiments were performed to examine the
efficiency of 3 to quench the emission of a fluorescent mole-
cule and it was found that the emission intensity of anthracene
Figure 4. Comparison of UV/Vis absorption spectra of HPB 2 (blue) and 7-helical HBC 3 (green).




significantly gets quenched after the successive addition of 3.
Theoretical calculations support the idea of anthracene being
enclosed within the NDI units (see Supporting Information S9
for further information). The successful development of the
synthetic strategy to HBC 3 opens up the access to a new
compound class, which can be described as HBC based, chiral
nano-tweezers having two structurally similar, p-extended ryle-
neimide arms. In this series, HBC 3 with its two NDI wings rep-
resents the smallest compound with promising structural fea-
tures stemming from the high pre-organisation of the diaza[7]-
helicene subunit. Using larger ryleneimides, to elongate the ar-
omatic tweezer-arms, will further increase the cavity of such
helical tweezers and, as a consequence, opens exciting oppor-
tunities for the supramolecular interaction with interdigitated
host molecules.
Conclusions
Two naphthalene diimide (NDI) units were fused to a hexaben-
zocorene (HBC) through a benzimidazole bridge for the first
time to generate a p-extended aza-helicene framework 3 that
was investigated with respect to its photophysical and chirop-
tical properties. The ortho-fusion of the NDI units to the HBC
leads to the formation of a fully conjugated diaza[7]helicene as
a new helical hybrid involving a wide lateral p-extension of the
helicene skeleton. During final Scholl oxidation, the 7-helical
HBC 3 was the only product formed out of three possible iso-
mers as pair of enantiomers, demonstrating pronounced ste-
reoselectivity of the formation process. The enantiomers were
separated by HPLC employing a chiral stationary phase. The
chiroptical properties investigated with circular dichroism (CD)
measurements were supported by theoretical calculations,
which also allowed for an assignment of the absolute configu-
ration of the isolated enantiomers. For a better understanding
as to why a hexaphenyl-benzene (HPB) precursor is forced to
adopt a 7-helical conformation and in order to prevent the for-
mation of unwanted side products, improved synthetic proto-
cols for the final Scholl oxidation are currently studied. The
synthetic access to aza[n]helicenes such as 3 will pave the way
for the exploration of unprecedent chiral nanotweezers with
two rigid functional arms. The use of the higher ryleneimide
analogues, in particular perylene-imides, to create a tweezer
with even longer and more extended p-surface, is currently
under investigation.
Figure 5. A) (M)- and (P)-configuration of 7-helcial HBC 3, tBu groups and swallow tail are omitted for clarity ; B) chiral separation of 3 (Chiralpak 1BN-5, n-hep-
tane/EtOH/diethylamine (DEA) 70:30:0.1, 4mLmin@1, RT); C) CD spectroscopy measurements of (M)-3 (black) and (P)-3 (blue) and the corresponding calculated
spectra (sTD-CAM-B3LYP/def2-TZVP with D3: grey, light blue; without D3 red, green).





Chemicals were purchased from Sigma–Aldrich and used without
any further purification. Solvents were distilled prior to usage. Thin
layer chromatography (TLC) was performed on Merck silica gel 60
F524, detected by UV light (254 nm, 366 nm). Plug chromatogra-
phy and column chromatography were performed on Macherey–
Nagel silica gel 60 M (deactivated, 230–400 mesh, 0.04–0.063 mm).
NMR spectra were recorded on a Bruker Avance 400 (1H: 400 MHz,
13C: 101 MHz), a Bruker Avance 500 (1H: 500 MHz, 13C: 126 MHz), or
a Bruker Avance Neo Cryo-Probe DCH (1H: 600 MHz, 13C: 151 MHz).
Deuterated solvents were purchased from Sigma–Aldrich and used
as received. Chemical shifts are given in ppm at room temperature
and are referenced to residual protic impurities in the solvents (1H:
CHCl3 : 7.24 ppm, C2H2Cl4 : 5.91 ppm) or the deuterated solvent
itself (13C{1H}: CDCl3 : 77.16 ppm, C2D2Cl4 : 74.20 ppm). The reso-
nance multiplicities are indicated as „s“ (singlet), „bs“ (broad sin-
glet), „d“ (doublet), „t“ (triplet), „q“ (quartet) and „m“ (multiplet).
Mass spectrometry was carried out with a Shimadzu AXIMA Confi-
dence (MALDI-TOF, matrix: 2,5-dihydroxybenzoic acid DHB, trans-2-
[3-(4-tert-butylphenyl)-2-methyl-2-propenyliden]malononitrile,
DCTB) or without matrix (OM). High resolution mass spectrometry
(HRMS) was recorded on a LDI/MALDI-ToF Bruker Ultraflex Extreme
machine or on a APPI-ToF mass spectrometer Bruker maXis 4G
UHR MS/MS spectrometer. UV/vis spectroscopy was carried out on
a Varian Cary 5000 UV-vis-NIR spectrometer. The spectra were re-
corded at rt in DCM in quartz cuvettes (edge length = 1 cm) under
ambient conditions. Fluorescence spectra were obtained from a
Shimadzu RF-5301 PC and a NanoLog spectrofluorometer (Horiba
Scientific). Circular dichroism spectroscopy was measured at rt in
DCM on a Jasco J-815 spectrometer. HPLC separation was carried
out using Shimadzu analytical and preparative HPLC with system
controller CBM-20A, solvent delivery unit LC-20A, autosampler SIL-
20A, column oven CTO-20A, photodiode array detector SPDM20A,
on-line degassing unit DGU-20A and low-pressure gradient unit. All
chromatograms were processed with Shimadzu LabSolution(c) soft-
ware and exported as ASCII files.
4/5-Bromo-1,2-naphthaleneimidebenzimidazole (5) and (12): A
dry flask was charged with NMI 8 (100 mg, 0.237 mmol, 1.1 equiv),
4-bromo-1,2-diaminbenzene 11 (40.0 mg, 0.216 mmol, 1 equiv) and
imidazole (800 mg) and the mixture was stirred under nitrogen at
160 8C for 3 h. The reaction mixture was cooled to rt, diluted in
DCM and washed with H2O. The combined organic layers were
concentrated under reduced pressure and the crude was purified
by silica gel column chromatography (SiO2, DCM/hexanes 1:1) to
provide the two separated isomers 5 and 12 in a pure form. Yields:
5 (44.0 mg, 0.077 mmol, 36 %), 12 (52.0 mg, 0.091 mmol, 42 %).
Figure 6. Geometry-optimised structures of HBC 3 at B3LYP/def2-SVP without dispersion correction; hydrogen atoms, tBu groups and swallow tail are omitted
for clarity ; A) top view with relevant distances between the two NDI arms; B) torsion angles of the inner helix ; C) side view with interplanar angle of the inner
helix ; D) representation of the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO).




4-Bromo-1,2-naphthaleneimidebenzimidazole (5): 1H NMR (CDCl3,
400 MHz, 25 8C): d= 8.87–8.66 (m, 4 H, Ar@CH), 8.54 (d, J = 1.8 Hz,
1 H, Ar@CH), 7.64 (d, J = 8.6 Hz, 1 H, Ar@CH), 7.51 (dd, J = 8.6, 1.9 Hz,
1 H, Ar@CH), 5.37–5.01 (m, 1 H, N@CH), 2.29–2.17 (m, 2 H, CH2),
1.96–1.67 (m, 2 H, CH2), 1.42–1.05 (m, 12 H, CH2), 0.92–0.68 (m, 6 H,
CH3) ppm;
13C NMR (CDCl3, 101 MHz 25 8C): d= 159.3 (C=O), 148.3,
143.0, 132.9 (Ar@C), 131.6, 130.0 (Ar@CH), 127.7 (Ar@C), 127.1 (Ar@
CH), 126.9, 125.9, 125.1 (Ar@C), 121.9 (Ar@CH), 120.5 (Ar@C), 119.1
(Ar@CH), 55.4 (N@CH), 32.4, 31.8, 26.8, 22.7 (CH2), 14.2 (CH3) ppm;
MS (MALDI-TOF, dctb): m/z = 572.2 (100 %, C31H31BrN3O3 [M+H]
+) ;
HRMS (APPI, CH2Cl2): calculated for C31H31BrN3O3 ([M+H]
+) m/z =
572.1543, found m/z = 572.1545; UV/Vis (CH2Cl2): l [nm] (e
[L mol@1 cm@1]) = 304 (23 500), 316 (26 500), 443 (18 500); Fluores-
cence (CH2Cl2): lexc. [nm] = 443, lemission [nm] (rel. int.) = 570 (100).
5-Bromo-1,2-naphthaleneimidebenzimidazole (12): 1H NMR
(CDCl3, 400 MHz, 25 8C): d= 8.97–8.56 (m, 4 H, Ar@CH), 8.24 (d, J =
8.5 Hz, 1 H, Ar@CH), 7.83 (d, J = 1.8 Hz, 1 H, Ar@CH), 7.47 (dd, J = 8.7,
1.8 Hz, 1 H, Ar@CH), 5.33–4.98 (m, 1 H, N@CH), 2.34–2.11 (m, 2 H,
CH2), 2.05–1.69 (m, 2 H, CH2), 1.41–0.96 (m, 12 H, CH2), 0.93–0.51 (m,
6 H, CH3) ppm;
13C NMR (CDCl3, 101 MHz 25 8C): d= 159.1 (C=O),
148.8, 145.2 (Ar@C), 131.6 (Ar@CH), 130.9 (Ar@C), 129.8 (Ar@CH),
127.6 (Ar@C), 127.2 (Ar@CH), 126.8, 125.8, 124.8 (Ar@C), 123.7 (Ar@
CH), 119.7 (Ar@C), 116.9 (Ar@CH), 55.4 (N@CH), 32.4, 31.8, 26.8, 22.7
(CH2), 14.2 (CH3) ppm; MS (MALDI-TOF, dctb): m/z = 572.2 (100 %,
C31H31BrN3O3 [M+H]
+) ; HRMS (MALDI-TOF, dctb): calculated for
C31H31BrN3O3 ([M+H]
+) m/z = 572.1543, found m/z = 572.1528; UV/
Vis (CH2Cl2): l [nm] (e [L mol
@1 cm@1]) = 300 (22 500), 312 (25 500),
420 (16 000); Fluorescence (CH2Cl2): lexc. [nm] = 420, lemission [nm]
(rel. int.) = 556 (100).
NDI-Tolane (6): A 20 mL MW vial was charged with Br-Naph 5
(70 mg, 0.12 mmol, 1 equiv), PdCl2(PPh3)2 (4.2 mg, 0.006 mmol,
0.05 equiv), CuI (0.5 mg, 0.003 mmol, 0.02 equiv) and toluene
(4 mL) and sealed with a septum. The solution was degassed for
15 min and subsequently di-tert-butyl(4-ethynyl-1,2-phenylene)di-
carbamate 4 (82.0 mg, 0.25 mmol, 2 equiv) dissolved in Et3N (2 mL)
was added via a syringe. The reaction mixture was stirred at 80 8C
overnight under argon atmosphere. The solvent was removed
under reduced pressure and the crude product was subjected to
column chromatography (SiO2 ; EtOAc/hexane 1:4) to provide the
pure product 6 as a red solid (83 mg, 0.10 mmol, 82 % yield). 1H
NMR (CDCl3, 400 MHz, 25 8C): d= 8.91–8.86 (m, 2 H, Ar@CH), 8.75
(bs, 2 H, Ar@CH), 8.61 (d, J = 1.5 Hz, 1 H, Ar@CH), 7.79 (d, J = 8.4 Hz,
1 H, Ar@CH), 7.69 (bs, 1 H, Ar@CH), 7.59 (m, 2 H, Ar@CH), 7.34 (dd,
J = 8.4, 1.9 Hz, 1 H, Ar@CH), 6.84 (bs, 1 H, N@H), 6.66 (bs, 1 H, N@H),
5.22–5.09 (m, 1 H, N@CH), 2.28–2.13 (m, 2 H, CH2), 1.92–1.78 (m, 2 H,
CH2), 1.53 (s, 9 H, CH3), 1.52 (s, 9 H, CH3), 1.35–1.18 (m, 12 H, CH2),
0.84–0.78 (m, 6 H, CH3) ppm;
13C NMR (CDCl3, 101 MHz 25 8C): d=
159.3, 153.9, 153.5 (C=O), 148.7, 143.8, 132.1, 131.5, 130.3, 129.2,
127.8, 127.2, 126.9, 126.0, 125.3, 122.2, 120.8, 119.2 (Ar@CH, Ar@C),
90.6, 89.6 (C/C), 81.4, 81.3 (C@CH3), 55.4 (N@CH), 32.4, 31.9 (CH2),
28.4 (CH3), 26.8, 22.7 (CH2), 14.2 (CH3) ppm; MS (MALDI-TOF, dctb):
m/z = 824.4 (C49H54N5O7 [M+H]
+) ; HRMS: (APPI, CH2Cl2) calculated
for C49H54N5O7 ([M+H]
+) m/z = 824.4018 found m/z = 824.4011; UV/
Vis (CH2Cl2): l [nm] (e [L mol
@1 cm@1]) = 328 (17 100), 480 (6700).
Di-NDI-Tolane (1) and (9): Compound 6 (80.0 mg, 0.097 mmol,
1 equiv) was dissolved in DCM/trifluoroacetic acid (8 mL, 1:1 v/v)
and stirred at room temperature for 3 h under nitrogen atmos-
phere.[21] Et3N was added for neutralization and the mixture was fil-
tered over silica. The solvent was removed under reduced pressure
and due to the sensitivity towards oxidation of di-amino tolane
7[22] the crude product was used in the next condensation reaction
without further purification and characterization. Approximately
62 mg (0.100 mmol, 1 equiv) of the crude di-amino tolane 7 and
naphthalene monoimide 8 (130 mg, 0.300 mmol, 3 equiv) were dis-
solved in DMF and heated to 140 8C for 18 h under argon atmos-
phere. The mixture was cooled to rt, extracted with DCM and
washed with water. The solvent was removed under reduced pres-
sure and the crude product was purified by plug chromatography
(SiO2 ; DCM) to provide the title compounds as an isomeric mixture
1 and 9 (54.0 mg, 0.054 mmol, 56 % yield). MS (MALDI-TOF, dctb):
m/z = 1009.5 (100 %, C64H60N6O6 [M+H]
+) ; HRMS: (APPI, CH2Cl2/Tol):
calculated for C64H60N6O6 ([M]
+) m/z = 1008.4569 found m/z =
1008.4595.
Di-NDI-HPB (2) and (10): A 1 mL MW-vial was charged with the
isomeric mixture of di-NDI-tolanes 9 and 10 (54.0 mg, 0.054 mmol,
1 equiv), tetrakis-(tert-butyl)tetracyclone[15a, 23] (50.0 mg, 0.081 mmol,
1.5 equiv) and toluene (1 mL) and sealed with a septum. The reac-
tion mixture was degassed with N2 for 5 min and heated to 220 8C
for 24 h. The solvent was removed under reduced pressure and
the crude was purified by column chromatography (SiO2, THF/
hexane 1:9) to provide the pure products 2 and 10. Yields: sym-
metric di-NDI-HPB 2 (25.0 mg, 0.015 mmol, 29 %), asymmetric di-
NDI-HPB 10 (26.0 mg, 0.016 mmol, 30 %).
Symmetric Di-NDI-HPB (2): 1H NMR (C2D2Cl4, 400 MHz, 135 8C): d=
8.81–8.50 (m, 8 H, Ar@CH), 8.14 (s, 2 H, Ar@CH), 7.33 (d, J = 8.4, 2 H,
Ar@CH), 7.20–7.11 (m, 2 H, Ar@CH), 6.93–6.66 (m, 16 H, Ar@CH),
5.17–5.02 (m, 2 H, N@CH), 2.24–2.12 (m, 4 H, CH2), 1.94–1.78 (m, 4 H,
CH2), 1.39–1.19 (m, 24 H, CH2), 1.11 (s, 18 H, CH3), 1.00 (s, 18 H, CH3),
0.86–0.72 (m, 12 H, CH3) ppm;
13C NMR (C2D2Cl4, 101 MHz, 120 8C):
d= 158.9, 158.6 (C=O), 147.9, 147.7, 147.41, 147.36, 141.6, 141.5,
141.4, 141.1, 141.0, 140.7, 140.6, 139.3, 139.1, 137.7, 137.6, 137.4,
131.04, 130.99, 130.71, 130.67, 130.6, 127.50, 127.47, 127.4, 126.1,
125.7, 125.6, 125.5, 123.3, 123.1, 120.4, 119.4, 119.0, 118.7, (Ar-CH,
Ar-C), 55.3 (N@CH), 34.0 (CH2), 32.4 (C@CH3), 31.7 (CH2), 31.28,
31.20, 31.18 (CH3), 26.6, 22.5 (CH2), 14.0 (CH3) ppm; MS (MALDI-TOF,
dctb): m/z = 1589.9 (100 %, C108H112N6O6 [M+H]
+) ; HRMS: (MALDI-
TOF, dctb): calculated for C108H112N6O6 ([M]
+) m/z = 1588.8638
found m/z = 1588.8652; UV/Vis (CH2Cl2): l [nm] (e [L mol
@1 cm@1]) =
322 (51 000), 471 (25 000); Fluorescence (CH2Cl2): lexc. [nm] = 471,
lemission [nm] (rel. int.) = 651 (100).
Asymmetric Di-NDI-HPB (10): 1H NMR (C2D2Cl4, 400 MHz, 135 8C):
d= 8.82–8.49 (m, 8 H, Ar@CH), 8.13 (dd, J = 1.6, 0.7 Hz, 1 H, Ar@CH),
7.94 (d, J = 8.4 Hz, 1 H, Ar@CH), 7.53 (d, J = 1.4 Hz, 1 H, Ar@CH), 7.34
(dd, J = 8.4, 0.7 Hz, 1 H, Ar@CH), 7.22 (dd, J = 8.4, 0.8 Hz, 1 H, Ar@
CH), 7.13 (dd, J = 8.3, 1.6 Hz, 1 H, Ar@CH), 6.89–6.71 (m, 16 H, Ar@
CH), 5.15–5.02 (m, 2 H, N@CH), 2.20–2.10 (m, 4 H, CH2), 1.92–1.80
(m, 4 H, CH2), 1.34–1.20 (m, 24 H, CH2), 1.13–1.08 (m, 18 H, CH3),
1.02 (s, 9 H, CH3), 0.97 (s, 9 H, CH3), 0.84–0.76 (m, 12 H, CH3) ppm;
13C NMR (C2D2Cl4, 101 MHz, 120 8C): d= 163.4, 163.2, 159.0 (C=O),
148.2, 148.1, 147.0, 147.9, 147.5, 147.4, 147.3, 146.0, 143.4, 141.9,
141.7, 141.6, 140.9, 140.8, 140.3, 140.2, 139.4, 139.2, 137.8, 137.7,
137.6, 131.3, 131.2, 130.6, 130.5, 129.8, 128.1, 128.0, 127.5, 127.4,
126.3, 125.8, 124.8, 124.8, 123.3, 123.2, 122.9, 118.8, 114.2, 113.7
(Ar@CH, Ar@C), 55.4 (N@CH), 34.0 (CH2), 32.9 (C@CH3), 31.4 (CH2),
31.2 (CH2), 31.20, 31.15, 31.09 (CH3), 22.3 (CH2), 13.7 (CH3) ppm; MS
(MALDI-TOF, dctb): m/z = 1590.1 (100 %, C108H112N6O6 [M+H]
+) ;
HRMS: (MALDI-TOF, dhb): calculated for C108H112N6O6 ([M]
+) m/z =
1588.8638 found m/z = 1588.8681; UV/Vis (CH2Cl2): l [nm] (e
[L mol@1 cm@1]) = 320 (37 500), 450 (18 000); Fluorescence (CH2Cl2):
lexc. [nm] = 451, lemission [nm] (rel. int.) = 649 (100).




7-Helical HBC (3): In a 20 mL MW-vial symmetrical di-NDI-HPB 2
(20.0 mg, 12.6 mmol, 1 equiv) was dissolved in DCM (20 mL) and
cooled to 0 8C with an ice bath. After degassing with N2 for 20 min
a solution of dry FeCl3 (120 mg, 0.378 mmol, 60 equiv) in MeNO2
(0.1 mL) was added. The mixture was degassed for further 15 min
and stirred overnight. The reaction was quenched via the addition
of MeOH. The solvent was removed under reduced pressure and
the crude product was purified by HPLC chromatography to pro-
vide the pure product 3 as a dark green solid (8.2 mg, 5.2 mmol,
43 %). 1H NMR (C2D2Cl4, 600 MHz, 25 8C): d= 10.03 (s, 2 H, Ar@CHCor),
9.58 (s, 2 H, Ar@CHCor), 9.40 (s, 2 H, Ar@CHCor), 9.35 (s, 2 H, Ar@CHCor),
9.32 (s, 2 H, Ar@CHCor), 9.06 (d, J = 7.6 Hz, 2 H, Ar@CHNaph), 8.66 (d,
J = 7.6 Hz, 2 H, Ar@CHNaph), 8.24 (d, J = 7.1 Hz, 2 H, Ar@CHNaph), 8.19
(d, J = 7.5 Hz, 2 H, Ar@CHNaph), 4.97–4.85 (m, 2 H, N@CH), 2.28–2.17
(m, 4 H, CH2), 2.00–1.92 (m, 4 H, CH2), 1.84 (s, 18 H, CH3), 1.79 (s,
18 H, CH3), 1.28–1.10 (m, 24 H, CH2), 0.79–0.71 (m, 12 H, CH3) ppm;
13C NMR (C2D2Cl4, 151 MHz, 25 8C): d= 156.8, 150.52 150.4, 149.7,
144.2, 130.9, 130.8, 130.7, 130.2, 129.9, 129.7, 128.4, 127.4, 127.3,
127.1, 126.5, 125.4, 124.0, 123.5, 122.1, 121.0, 120.8, 120.6, 120.0,
119.8, 119.7, 119.1, 115.4 (Ar-CH, Ar-C), 55.4 (N-CH), 36.2, 36.1 (C@
CH3), 32.4, 32.3 (CH3) 31.8, 30.0, 26.9, 22.8 (CH2) 14.4 (CH3) ppm; MS
(MALDI-TOF, dctb): m/z = 1577.8 (100 %, C108H100N6O6 [M]
+) ; HRMS:
(MALDI-TOF, dctb): calculated for (C108H100N6O6 [M]
+) m/z =
1576.7699, found m/z = 1576.7696; UV/Vis (CH2Cl2): l [nm] (e
[L mol@1 cm@1]) = 372 (54 000), 571 (11100).
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